ES2161354T3 - Compuestos mimeticos de la hoja beta y su uso como inhibidores de proteasas. - Google Patents
Compuestos mimeticos de la hoja beta y su uso como inhibidores de proteasas.Info
- Publication number
- ES2161354T3 ES2161354T3 ES96910566T ES96910566T ES2161354T3 ES 2161354 T3 ES2161354 T3 ES 2161354T3 ES 96910566 T ES96910566 T ES 96910566T ES 96910566 T ES96910566 T ES 96910566T ES 2161354 T3 ES2161354 T3 ES 2161354T3
- Authority
- ES
- Spain
- Prior art keywords
- beta
- protease inhibitors
- beta sheet
- mimetic compounds
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 102000014400 SH2 domains Human genes 0.000 abstract 1
- 108050003452 SH2 domains Proteins 0.000 abstract 1
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
- Materials For Medical Uses (AREA)
- Paper (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41051895A | 1995-03-24 | 1995-03-24 | |
| US54900695A | 1995-10-27 | 1995-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2161354T3 true ES2161354T3 (es) | 2001-12-01 |
Family
ID=27021026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96910566T Expired - Lifetime ES2161354T3 (es) | 1995-03-24 | 1996-03-25 | Compuestos mimeticos de la hoja beta y su uso como inhibidores de proteasas. |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP0815123B1 (enExample) |
| JP (4) | JPH10508034A (enExample) |
| AT (1) | ATE206433T1 (enExample) |
| AU (2) | AU713530B2 (enExample) |
| CA (2) | CA2215720A1 (enExample) |
| DE (1) | DE69615671T2 (enExample) |
| ES (1) | ES2161354T3 (enExample) |
| WO (1) | WO1996030035A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5719296A (en) * | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
| AU7604196A (en) * | 1995-10-30 | 1997-05-22 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
| US5840835A (en) * | 1995-10-30 | 1998-11-24 | Merck & Co., Inc. | Inhibitors of peptide binding to MHC class II proteins |
| US5817757A (en) * | 1995-10-30 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of peptide binding to MHO class II proteins |
| GB9702377D0 (en) * | 1996-02-23 | 1997-03-26 | Zeneca Ltd | Peptide derivatives |
| NZ332347A (en) | 1996-06-07 | 2000-05-26 | Zeneca Ltd | Peptide derivatives containing a hydrophobic group, L-amino acid residues and modified L-amino acid residues |
| CA2253835A1 (en) * | 1996-06-18 | 1997-12-24 | Kent Alan Berryman | Process for the preparation of chiral keto-heterocycles of basic amino acids |
| EP1661566A3 (en) * | 1996-08-05 | 2008-04-16 | Myriad Genetics, Inc. | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| ES2262184T3 (es) * | 1996-08-05 | 2006-11-16 | Myriad Genetics, Inc. | Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion. |
| GB9621836D0 (en) | 1996-10-19 | 1996-12-11 | Zeneca Ltd | Peptide compounds |
| GB9624562D0 (en) | 1996-11-27 | 1997-01-15 | Zeneca Ltd | Peptide derivatives |
| GB9625865D0 (en) * | 1996-12-12 | 1997-01-29 | Zeneca Ltd | Peptides |
| EP1053246B1 (en) * | 1998-02-12 | 2003-01-02 | Molecumetics, Ltd. | Beta-sheet mimetics and methods relating to the use thereof |
| US6323219B1 (en) | 1998-04-02 | 2001-11-27 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for treating immunomediated inflammatory disorders |
| US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
| US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
| BR0007778A (pt) | 1999-01-27 | 2002-06-04 | Ortho Mcneil Pharm Inc | Peptidila cetonas heterocìclicas úteis como inibidores de triptase |
| US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
| WO2001064678A2 (en) * | 2000-02-29 | 2001-09-07 | Bristol-Myers Squibb Pharma Company | Inhibitors of hepatitis c virus ns3 protease |
| US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
| US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
| JPWO2011096440A1 (ja) | 2010-02-03 | 2013-06-10 | 株式会社 ＰＲＩＳＭ ＢｉｏＬａｂ | 天然変性タンパク質に結合する化合物およびそのスクリーニング方法 |
| EP3204352B1 (en) | 2014-10-06 | 2020-07-01 | Cortexyme, Inc. | Inhibitors of lysine gingipain |
| EP3374352A4 (en) | 2015-11-09 | 2019-10-02 | Cortexyme, Inc. | GINGIPAINE ARGININE INHIBITORS |
| IL265389B1 (en) | 2016-09-16 | 2026-07-01 | Quince Therapeutics Inc | Ketone compounds lysine inhibitors gingerapine, preparations containing them and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA896851B (en) * | 1988-09-14 | 1990-06-27 | Hoffmann La Roche | Use of ace-inhibitors |
-
1996
- 1996-03-25 CA CA002215720A patent/CA2215720A1/en not_active Abandoned
- 1996-03-25 EP EP96910566A patent/EP0815123B1/en not_active Expired - Lifetime
- 1996-03-25 WO PCT/US1996/004044 patent/WO1996030035A1/en not_active Ceased
- 1996-03-25 EP EP96910547A patent/EP0817642A1/en not_active Withdrawn
- 1996-03-25 AU AU53729/96A patent/AU713530B2/en not_active Ceased
- 1996-03-25 DE DE69615671T patent/DE69615671T2/de not_active Expired - Fee Related
- 1996-03-25 CA CA002215695A patent/CA2215695C/en not_active Expired - Fee Related
- 1996-03-25 AU AU53714/96A patent/AU712581B2/en not_active Ceased
- 1996-03-25 JP JP8529567A patent/JPH10508034A/ja active Pending
- 1996-03-25 AT AT96910566T patent/ATE206433T1/de not_active IP Right Cessation
- 1996-03-25 JP JP8529594A patent/JPH10508035A/ja not_active Withdrawn
- 1996-03-25 ES ES96910566T patent/ES2161354T3/es not_active Expired - Lifetime
-
2000
- 2000-03-21 JP JP2000079170A patent/JP2000319295A/ja not_active Withdrawn
-
2004
- 2004-01-26 JP JP2004017703A patent/JP4152900B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0817642A1 (en) | 1998-01-14 |
| WO1996030035A1 (en) | 1996-10-03 |
| AU5371496A (en) | 1996-10-16 |
| JPH10508035A (ja) | 1998-08-04 |
| JP4152900B2 (ja) | 2008-09-17 |
| AU712581B2 (en) | 1999-11-11 |
| CA2215720A1 (en) | 1996-10-03 |
| AU713530B2 (en) | 1999-12-02 |
| DE69615671T2 (de) | 2002-08-08 |
| JP2004131511A (ja) | 2004-04-30 |
| DE69615671D1 (de) | 2001-11-08 |
| CA2215695C (en) | 2003-09-16 |
| CA2215695A1 (en) | 1996-10-03 |
| AU5372996A (en) | 1996-10-16 |
| EP0815123B1 (en) | 2001-10-04 |
| JP2000319295A (ja) | 2000-11-21 |
| JPH10508034A (ja) | 1998-08-04 |
| EP0815123A1 (en) | 1998-01-07 |
| ATE206433T1 (de) | 2001-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE206433T1 (de) | Beta-schleifenähnliche verbindungen und deren verwendung als protease-inhibitoren | |
| CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
| FI972390A0 (fi) | Sytokiini nimeltä Lerk-7 | |
| EP1712623A3 (en) | Selection of proteins using RNA-protein fusions | |
| DE59903410D1 (de) | Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung | |
| EP1159441B8 (en) | Delivery of nucleic acids and proteins to cells | |
| ATE293159T1 (de) | Stabilisierendes verdünnungsmittel für polypeptide und antigene | |
| ATE469981T1 (de) | Tests auf proteinkinasen mit fluoreszierenden proteinsubstraten | |
| DK0996409T3 (da) | Præparat til at forsinke hårvækst og tilsvarende anvendelse | |
| PT973806E (pt) | Modificacao de proteinas com locais protegidos | |
| ATE368682T1 (de) | Als 2f1 bezeichnetes rezeptorprotein | |
| ATE532533T1 (de) | Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen | |
| BR0009421A (pt) | Inibidores de ligação lfa-1 aos icams e uso dos mesmos | |
| ATE262537T1 (de) | Proliferationsinhibitor von endothellzellen und dessen verwendung | |
| DK0877803T3 (da) | OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder | |
| AU7571998A (en) | Rapid evaluation of the ratio of biological molecules | |
| IL157047A0 (en) | Methods and devices for quantitation of glycated protein | |
| CA2529001A1 (en) | Binding peptides: methods for their generation and use | |
| SE9602822D0 (sv) | New receptor | |
| ATE305612T1 (de) | Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität | |
| EP1023906A4 (en) | POTENTIATOR FOR ANTI-TUMOR ANTIBODY LYMPHOID | |
| FI971580A7 (fi) | Stabiloiva väliaine virtsassa olevalle aGST:lle käytettäväksi entsyymi -immunokokeessa | |
| DE69738945D1 (de) | Rken | |
| ATE293163T1 (de) | Cyclin e spezifische konstrukte und komplexe | |
| ATE210465T1 (de) | Konjugat aus einem wirkstoff und einem nicht als körperfremd angesehenen, nativen protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 815123 Country of ref document: ES |